A trial looking at mini stem cell transplant for people with leukaemia or lymphoma (Campath 1H dose reduction study)

Overview

Cancer types:

Acute leukaemia, Blood cancers, Chronic leukaemia, Hodgkin lymphoma, Leukaemia, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Results

Phase:

Phase 2

Details

This trial was looking to see if using a lower dose of the monoclonal antibody Campath 1H could help reduce complications of mini stem cell transplants.

Recruitment start: 1 September 2003

Recruitment end: 31 January 2007

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor S. MacKinnon

Supported by

Experimental Cancer Medicine Centre (ECMC)

National Institute for Health Research Cancer Research Network (NCRN)

Schering Healthcare Ltd

University College London (UCL)

Last reviewed: 13 December 2013

CRUK internal database number: 517

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.